DK0733371T3 - Middel til subkutan administrering af protein C - Google Patents

Middel til subkutan administrering af protein C

Info

Publication number
DK0733371T3
DK0733371T3 DK96103663T DK96103663T DK0733371T3 DK 0733371 T3 DK0733371 T3 DK 0733371T3 DK 96103663 T DK96103663 T DK 96103663T DK 96103663 T DK96103663 T DK 96103663T DK 0733371 T3 DK0733371 T3 DK 0733371T3
Authority
DK
Denmark
Prior art keywords
protein
agent
subcutaneous administration
compsns
compsn
Prior art date
Application number
DK96103663T
Other languages
English (en)
Inventor
Johann Dr Eibl
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26013573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0733371(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19608218A external-priority patent/DE19608218A1/de
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0733371T3 publication Critical patent/DK0733371T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK96103663T 1995-03-21 1996-03-08 Middel til subkutan administrering af protein C DK0733371T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510260 1995-03-21
DE19608218A DE19608218A1 (de) 1995-03-21 1996-03-04 Mittel zur subkutanen Verabreichung von Protein C

Publications (1)

Publication Number Publication Date
DK0733371T3 true DK0733371T3 (da) 2002-10-07

Family

ID=26013573

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96103663T DK0733371T3 (da) 1995-03-21 1996-03-08 Middel til subkutan administrering af protein C

Country Status (7)

Country Link
US (1) US5827818A (da)
EP (1) EP0733371B1 (da)
JP (1) JPH08268910A (da)
AT (1) ATE219375T1 (da)
CA (1) CA2172217A1 (da)
DK (1) DK0733371T3 (da)
ES (1) ES2179129T3 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324556A1 (en) * 2001-07-25 2003-02-17 Protein Design Labs, Inc. Stable lyophilized pharmaceutical formulation of igg antibodies
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
AT402260B (de) * 1990-08-16 1997-03-25 Immuno Ag Protein c-hältige pharmazeutische präparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
US5279956A (en) * 1991-06-24 1994-01-18 The Scripps Research Institute Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C

Also Published As

Publication number Publication date
ATE219375T1 (de) 2002-07-15
US5827818A (en) 1998-10-27
EP0733371A1 (de) 1996-09-25
JPH08268910A (ja) 1996-10-15
ES2179129T3 (es) 2003-01-16
EP0733371B1 (de) 2002-06-19
CA2172217A1 (en) 1996-09-22

Similar Documents

Publication Publication Date Title
EE03058B1 (et) Apolipoproteiini molekulaarse teisendi dimeer ja selle valmistamismeetod
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
ATE82858T1 (de) N-terminale fragmente von menschlichem serumalbumin.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ATA175988A (de) Extraktionsmittel fuer poly-d(-)-3-hydroxybutter- saeure
ATE216400T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protein-domäne ns3aus dem virus von hepatitis c und ns4a enthalten und damit bereitgestellte kristalle
DK0652966T3 (da) Fremgangsmåde til forøgelse af ekspression af virale proteiner
SE7407445L (da)
KR850007275A (ko) 기능성 인체인자 ⅷ의 제조방법
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
ES2053449T3 (es) Analogos (tpa) de activadores de plasminogeno de tejido.
KR910009246A (ko) 폴리펩타이드를 함유하는 피하투여용 또는 근육내 투여용 약제
DE69430868D1 (de) Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten
Mann et al. The molecular weights of bovine thrombin and its primary autolysis products
DE69024104D1 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
DK0563093T4 (da) Præparat anvendt som terapeutisk middel mod kroniske virale hepatitissygdomme
EP0422125A4 (en) Platelet blocking peptides
ES2157978T3 (es) Edulcorante de brazeina.
ATA123991A (de) Arzneimittel enthaltend aktiviertes protein c
ATE94070T1 (de) Faktor xiii zur vorbeugung von intraventrikulaeren blutungen.
AU2308992A (en) Cysteine depleted il-6 muteins
DE69231401D1 (de) Herstellung von faktor-ix
DK0502313T3 (da) Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv
ATE219375T1 (de) Mittel zur subkutanen verabreichung von protein c
ATE59781T1 (de) Potenzierung von prazosin.